VCANBIO(SH:600645) Tong Hua Shun Cai Bao·2025-04-24 14:47Financial Performance - The basic earnings per share for 2024 is 0.2200 yuan, a decrease of 4.35% compared to 2023's 0.2300 yuan [1] - The net profit for 2024 is 1 billion yuan, down 5.66% from 1.06 billion yuan in 2023 [1] - The return on equity for 2024 is 2.77%, a decline of 5.78% from 2.94% in 2023 [1] - The total operating revenue for 2024 is 15.85 billion yuan, slightly down by 0.31% from 15.9 billion yuan in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 14,465.33 million shares, accounting for 30.91% of the circulating shares, which is a decrease of 455.98 million shares from the previous period [1] - Tianjin Deyuan Health Management Co., Ltd. holds 5,678.75 million shares, representing 12.14% of the total share capital, unchanged from the previous period [2] - Shenzhen Jiadao Successful Investment Enterprise (Limited Partnership) holds 4,494.38 million shares, accounting for 9.61%, also unchanged [2] - Hong Kong Central Clearing Limited has reduced its holdings by 502.01 million shares, now holding 1,463.05 million shares, which is 3.13% of the total [2] Dividend Distribution - The company has announced no distribution or capital increase for the current period [3]